Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Optom Vis Sci. 2022 Mar 1;99(3):213–227. doi: 10.1097/OPX.0000000000001867

Appendix Table A4.

Distribution of Stereoacuity Scores and Change in Stereoacuity Scores from Baseline by Treatment Group (Limited to Participants without Strabismus).

Baseline 4 weeksa S weeksa

Binocular
Treatment
Continued
Spectacles
Binocular
Treatment
Continued
Spectacles
Binocular
Treatment
Continued
Spectacles

N % N % N % N % N % N %

Per Group (N) 61 54 58 51 5l 51

Stereoacuity (Seconds of Arc) b
 Missing/Not done 0 0% 2 4% 4 7% 4 8% 4 7% 5 10%
 Nil 15 25% 11 20% 11 19% 8 16% 11 19% 8 16%
 2000 9 15% 6 11% 5 9% 7 14% 7 12% 2 4%
 800 5 8% 5 9% 8 14% 4 8% 5 9% 8 16%
 400 10 16% 12 22% 8 14% 10 20% 5 9% 8 16%
 200 10 16% 12 22% 9 16% 9 18% 11 19% 8 16%
 100 9 15% 3 6% 10 1l% 4 8% 9 16% 6 12%
 60 1 2% 2 4% 3 5% 4 8% 2 4% 2 4%
 40 2 3% 1 2% 0 0% 1 2% 3 5% 4 8%
 Median (Range) 400 (40 to Nil) 400 (40 to Nil) 400 (60 to Nil) 400 (40 to Nil) 400 (40 to Nil) 400 (40 to Nil)

Change in Level of Stereoacuity from Baseline c
 ≥ 2 Levels Worse 8 15% 6 13% 5 9% 3 7%
 Within 1 Level 37 69% 34 l6% 40 l5% 30 6l%
 ≥ 2 Levels Better 9 1l% 5 11% 8 15% 12 27%
a

Limited to follow-up visits completed within the pre-specified analysis windows.

b

Results of the Randot Butterfly stereoacuity test were analyzed as 2000 seconds of arc (if correct response) or nil (if incorrect response) in the presence of an incorrect response on the 800 seconds of arc level of the Randot Preschool stereoacuity test.

c

The exact Wilcoxon rank-sum test was used to compare the change in stereoacuity from baseline to the 4-week visit (Bonferroni-adjusted P > .99) and to the 8-week visit (Bonferroni-adjusted P > .99) between treatment groups for participants without strabismus.